Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. C. Deaton, E.S. Froelicher, L.H. Wu, C. Ho, K. Shishani, T. Jaarsma, The global burden of cardiovascular disease. Eur. J. Cardiovasc. Nurs. 10, 5–13 (2011)
2. R.-X. Yin, D.-Z. Yang, J.-Z. Wu, Nanoparticle drug-and gene-eluting stents for the prevention and treatment of coronary restenosis. Theranostics 4, 175 (2014)
3. J. Puel, B. Lacapere, M. Sabathier, R. Schmitt, J.P. Monassier, B. Valeix, P. Labrunie, J.P. Bounhoure, Coronary revascularization at the acute phase of myocardial infarction. Short and median-term survival of 359 patients. Multicenter study. Arch. Mal. Coeur Vaiss. 79, 409–417 (1986)
4. T. Palmerini, G. Biondi-Zoccai, D. Della-Riva, A. Mariani, P. Genereux, A. Branzi, G.W. Stone, Stent thrombosis with drug-eluting stents: is the paradigm shifting? J. Am. Coll. Cardiol. 62, 1915–1921 (2013)
5. X. Ma, S. Oyamada, F. Gao, T. Wu, M.P. Robich, H. Wu, X. Wang, B. Buchholz, S. Mccarthy, Z. Gu, C.F. Bianchi, F.W. Sellke, R. Laham, Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies. J. Pharm. Biomed. Anal. 54, 807–811 (2012)